Athira Pharma, Inc.

Practice Area: 
Stock Symbol: 
Case Status: 

Ademi LLP is investigating possible securities fraud claims against Athira (NASDAQ: ATHA).  The investigation results from inaccurate statements Athira may have made regarding its business operations and prospects.

The investigation focuses on whether Acadia properly disclosed the facts underlying doctoral research conducted by Leen Kawas, PhD, President and Chief Executive Officer of Athira, at Washington State University.  Athira was founded by Kawas and others based on research conducted at Washington State and subsequent peer review has suggested that images in papers authored by Kawas could have been manipulated.